272 related articles for article (PubMed ID: 31207279)
1. Design and in vitro evaluation of doxycycline hyclate niosomes as a potential ocular delivery system.
Gugleva V; Titeva S; Rangelov S; Momekova D
Int J Pharm; 2019 Aug; 567():118431. PubMed ID: 31207279
[TBL] [Abstract][Full Text] [Related]
2. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
3. Engineering of polymer-surfactant nanoparticles of doxycycline hydrochloride for ocular drug delivery.
Pokharkar V; Patil V; Mandpe L
Drug Deliv; 2015; 22(7):955-68. PubMed ID: 24601827
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of lomefloxacin Hcl ocular efficacy via niosomal encapsulation: in vitro characterization and in vivo evaluation.
Khalil RM; Abdelbary GA; Basha M; Awad GEA; El-Hashemy HA
J Liposome Res; 2017 Dec; 27(4):312-323. PubMed ID: 27241274
[TBL] [Abstract][Full Text] [Related]
5. Formulation and evaluation of niosomal nasal drug delivery system of folic acid for brain targeting.
Ravouru N; Kondreddy P; Korakanchi D; Haritha M
Curr Drug Discov Technol; 2013 Dec; 10(4):270-82. PubMed ID: 23863098
[TBL] [Abstract][Full Text] [Related]
6. Potential use of niosomal hydrogel as an ocular delivery system for atenolol.
Abu Hashim II; El-Dahan MS; Yusif RM; Abd-Elgawad AE; Arima H
Biol Pharm Bull; 2014; 37(4):541-51. PubMed ID: 24694602
[TBL] [Abstract][Full Text] [Related]
7. Hydroxychloroquine niosomes: a new trend in topical management of oral lichen planus.
Bendas ER; Abdullah H; El-Komy MH; Kassem MA
Int J Pharm; 2013 Dec; 458(2):287-95. PubMed ID: 24184035
[TBL] [Abstract][Full Text] [Related]
8. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
Junyaprasert VB; Singhsa P; Suksiriworapong J; Chantasart D
Int J Pharm; 2012 Feb; 423(2):303-11. PubMed ID: 22155414
[TBL] [Abstract][Full Text] [Related]
9. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
El-Nabarawi MA; Abd El Rehem RT; Teaima M; Abary M; El-Mofty HM; Khafagy MM; Lotfy NM; Salah M
Drug Dev Ind Pharm; 2019 Jun; 45(6):922-936. PubMed ID: 30744431
[TBL] [Abstract][Full Text] [Related]
10. Niosome-encapsulated Doxycycline Hyclate for Potentiation of Acne Therapy: Formulation and Characterization.
Kashani-Asadi-Jafari F; Hadjizadeh A
Pharm Nanotechnol; 2022; 10(1):56-68. PubMed ID: 35209832
[TBL] [Abstract][Full Text] [Related]
11. Enhanced ocular bioavailability of fluconazole from niosomal gels and microemulsions: formulation, optimization, and in vitro-in vivo evaluation.
Soliman OAE; Mohamed EA; Khatera NAA
Pharm Dev Technol; 2019 Jan; 24(1):48-62. PubMed ID: 29210317
[TBL] [Abstract][Full Text] [Related]
12. Formulation and evaluation of niosomal vesicles containing ondansetron HCL for trans-mucosal nasal drug delivery.
Teaima MH; El Mohamady AM; El-Nabarawi MA; Mohamed AI
Drug Dev Ind Pharm; 2020 May; 46(5):751-761. PubMed ID: 32250181
[TBL] [Abstract][Full Text] [Related]
13. In vitro characterisation of Span 65 niosomal formulations containing proteins.
Haj-Ahmad RR; Elkordy AA; Chaw CS
Curr Drug Deliv; 2015; 12(5):628-39. PubMed ID: 25963305
[TBL] [Abstract][Full Text] [Related]
14. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
Jain N; Verma A; Jain N
Drug Deliv; 2020 Dec; 27(1):888-899. PubMed ID: 32551978
[TBL] [Abstract][Full Text] [Related]
15. Sorbitane Monostearate and Cholesterol based Niosomes for Oral Delivery of Telmisartan.
Ahad A; Raish M; Al-Jenoobi FI; Al-Mohizea AM
Curr Drug Deliv; 2018 Feb; 15(2):260-266. PubMed ID: 28521674
[TBL] [Abstract][Full Text] [Related]
16. Preparation of niosomes as an ocular delivery system for naltrexone hydrochloride: physicochemical characterization.
Abdelkader H; Ismail S; Kamal A; Alany RG
Pharmazie; 2010 Nov; 65(11):811-7. PubMed ID: 21155387
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo evaluation of Bola-surfactant containing niosomes for transdermal delivery.
Paolino D; Muzzalupo R; Ricciardi A; Celia C; Picci N; Fresta M
Biomed Microdevices; 2007 Aug; 9(4):421-33. PubMed ID: 17252206
[TBL] [Abstract][Full Text] [Related]
18. Effect of surfactants on the characteristics of fluconazole niosomes for enhanced cutaneous delivery.
Gupta M; Vaidya B; Mishra N; Vyas SP
Artif Cells Blood Substit Immobil Biotechnol; 2011 Dec; 39(6):376-84. PubMed ID: 21951195
[TBL] [Abstract][Full Text] [Related]
19. Intranasal niosomes of nefopam with improved bioavailability: preparation, optimization, and in-vivo evaluation.
Abou-Taleb HA; Khallaf RA; Abdel-Aleem JA
Drug Des Devel Ther; 2018; 12():3501-3516. PubMed ID: 30410310
[TBL] [Abstract][Full Text] [Related]
20. Single Intravenous Dose of Novel Flurbiprofen-Loaded Proniosome Formulations Provides Prolonged Systemic Exposure and Anti-inflammatory Effect.
Verma P; Prajapati SK; Yadav R; Senyschyn D; Shea PR; Trevaskis NL
Mol Pharm; 2016 Nov; 13(11):3688-3699. PubMed ID: 27632682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
